Australia markets close in 2 hours 52 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
160.35+1.76 (+1.11%)
At close: 04:00PM EDT
161.00 +0.65 (+0.41%)
After hours: 07:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
21,190,900
18,976,700
482,325
108,589
127,575
Cost of revenue
5,070,600
3,860,700
704,362
243,827
156,730
Gross profit
16,120,300
15,116,000
-222,037
-135,238
-29,155
Operating expenses
Research development
-
-
2,033
226,466
143,040
Selling general and administrative
473,100
328,900
101,424
43,410
27,090
Total operating expenses
369,600
200,100
-132,618
46,280
24,698
Operating income or loss
15,750,700
14,915,900
-89,419
-181,518
-53,853
Interest expense
14,100
5,400
2,003
1,718
1,721
Total other income/expenses net
996,500
156,300
-52,896
2,341
5,966
Income before tax
16,718,700
15,046,400
-145,802
-179,440
-47,662
Income tax expense
4,970,700
4,753,900
-161,000
-268
600
Income from continuing operations
11,748,000
10,292,500
15,198
-179,172
-48,262
Net income
11,748,000
10,292,500
15,198
-179,056
-48,019
Net income available to common shareholders
11,748,000
10,292,500
15,198
-179,056
-48,019
Basic EPS
-
42.18
0.06
-0.85
-0.21
Diluted EPS
-
39.63
0.06
-0.85
-0.21
Basic average shares
-
244,000
253,300
212,057
226,859
Diluted average shares
-
259,700
253,300
212,057
226,859
EBITDA
-
15,127,000
-105,055
-143,826
-23,957